[Whitepaper] Tracking sentiment among life-science leaders

High expectations of competition and growth  

Our latest white paper, Informed Optimism and Resilience in the Life-Science Sector, summarizes the key findings of our 2024/2025 Springer Nature Life Science Market Sentiment Survey.  

The report gives an insight into the views of senior professionals on what’s shaping the industry today and their priorities and predictions for tomorrow. Download the full report here >>> 

A dynamic landscape 

Despite ongoing geopolitical shifts, economic uncertainties and regulatory changes, we found that life-science leaders entered 2025 with an overall mood of pragmatism and confidence. 

As we move into the second half of the year, the market remains in a dynamic phase. Leaders will need to continue adapting quickly, strengthening points of differentiation, identifying areas with potential for impact and building thought leadership.

Challenges and opportunities 

While most life-science leaders anticipate market growth and investment over the coming months and years, more than two thirds also expect an increase in competition, with just 2% predicting this will fall. 

To remain competitive, respondents say their strategic priorities include focusing on customer-centric targeting for new audiences or regions, launching new products and repositioning existing ones. 

About our survey 

We conducted the survey between November 2024 and February 2025, and received responses from 160 senior sales, marketing and R&D professionals, across 31 countries. 

More than two in three participants had over ten years’ experience in their field. These included specialists in a range of sub-sectors including biotech, diagnostics, laboratory equipment and services, medical devices, pharmaceuticals and reagent supply.  

Want to dive deeper? 

Our white paper provides in-depth insights into what life-science leaders view as the key drivers and emerging trends in the sector. 

We welcome your views on the opinions expressed in the survey and your thoughts on where the life-science market is heading. 

If you’d like to see the full white paper, download it here >>>